Sign inJoin waitlistJoin the waitlist

FR

Frederic Reu

Medical Oncology

Credentials: · ·

History

Cleveland Clinic Foundation
2001–2004
Internal Medicine
1998–2001
Medical School
1994–1998

Research

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous…
The Lancet · 2017 · 760 citations
A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma
Blood · 2012 · 535 citations
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis
Cell Death and Differentiation · 2004 · 307 citations

HL
Hien Liu
6 papers
Matt Kalaycio
6 papers
MA
Melissa Alsina
6 papers
Beth Faiman
5 papers
Robert Dean
5 papers
Robert Orlowski
5 papers
Ronald Sobecks
5 papers
Yogen Saunthararajah
5 papers
Christy Samaras
4 papers
Eric Hsi
4 papers
EB
Ernest Borden
4 papers
GS
George Somlo
4 papers